Hirumi H, Martin S, Hirumi K, Inoue N, Kanbara H, Saito A, Suzuki N
Research Center for Protozoan Molecular Immunology, Obihiro University of Agriculture and Veterinary Medicine, Hokkaido, Japan.
Trop Med Int Health. 1997 Mar;2(3):240-4. doi: 10.1046/j.1365-3156.1997.d01-268.x.
Bloodstream forms of Trypanosoma brucei and T. evansi have been cultivated in an axenic culture system by using Iscove's modified DMEM-based HMI-9 medium supplemental with bathocuproinedisulphonic acid, L-cysteine, hypoxanthine, 2-mercaptoethanol, pyruvate, thymidine and 10% fetal bovine or adult horse serum. We developed a serum-free medium (HMI-244) in which serum in HMI-9 was replaced by fatty acid-free bovine serum albumin, bovine alpha 2-macroglobulin, bovine beta-lipoprotein, d-biotin, retinol, beta-alanine, L-anserine nitrate salt, L-ornithine hydrochloride, O-phosphorylethanolamine, sarcosine, taurine, adenosine-5'-triphosphate, 2'-deoxycytidine-5'-monophosphate, 2'-deoxyguanosine-5'-monophosphate, and 5-methyltetrahydrofolic acid. Maximum cell densities and population doubling times were 2.6 x 10(6) cells/ml; 10.6 hours and 2.2 x 10(6) cells/ml; 10.9 hours for T. brucei and T. evansi, respectively. Bloodstream forms continued to proliferate in the serum-free cultures for more than 90 days and the trypomastigotes retained their morphological characteristics and infectivity to mice. If validated, this serum-free medium may help reduce future interlaboratory variability in biochemical, immunological, molecular biological and drug sensitivity studies on these parasites.
布氏锥虫和伊氏锥虫的血流形式已在无血清培养系统中培养,使用的是基于Iscove改良的DMEM的HMI - 9培养基,并补充了 bathocuproinedisulphonic acid、L - 半胱氨酸、次黄嘌呤、2 - 巯基乙醇、丙酮酸盐、胸腺嘧啶核苷和10%胎牛血清或成年马血清。我们开发了一种无血清培养基(HMI - 244),其中HMI - 9中的血清被无脂肪酸牛血清白蛋白、牛α2 - 巨球蛋白、牛β - 脂蛋白、d - 生物素、视黄醇、β - 丙氨酸、L - 鹅肌肽硝酸盐、L - 鸟氨酸盐酸盐、O - 磷酸乙醇胺、肌氨酸、牛磺酸、腺苷 - 5'- 三磷酸、2'- 脱氧胞苷 - 5'- 单磷酸、2'- 脱氧鸟苷 - 5'- 单磷酸和5 - 甲基四氢叶酸所取代。布氏锥虫和伊氏锥虫的最大细胞密度和群体倍增时间分别为2.6×10⁶个细胞/毫升;10.6小时和2.2×10⁶个细胞/毫升;10.9小时。血流形式在无血清培养中持续增殖超过90天,并且锥鞭毛体保留了它们的形态特征和对小鼠的感染性。如果得到验证,这种无血清培养基可能有助于减少未来这些寄生虫在生化、免疫、分子生物学和药物敏感性研究中的实验室间差异。